PODD - INSULET CORP

QQQ $ 473.14 $ -2.10 (-0.44 %)

DIA $ 417.33 $ 2.44 (0.59 %)

SPY $ 562.48 $ 0.83 (0.15 %)

TLT $ 101.29 $ 0.92 (0.92 %)

GLD $ 238.61 $ -0.02 (-0.01 %)

Previous Close

$ 233.89

Open

Bid

$ 233.73 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 125.82 - $ 236.62

Volume

550,862

Average Volume

Market Cap

16.4B

Beta (5Y Monthly)

$ 1.17

PE Ratio (TTM)

$ 41.49

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-23-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-05-2023	03-31-2023	10-Q
7	02-24-2023	12-31-2022	10-K
8	11-04-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-23-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-07-2021	03-31-2021	10-Q
15	02-24-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-07-2020	06-30-2020	10-Q
18	05-08-2020	03-31-2020	10-Q
19	02-26-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-03-2019	03-31-2019	10-Q
23	02-26-2019	12-31-2018	10-K
24	11-02-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-04-2018	03-31-2018	10-Q
27	02-22-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-04-2017	06-30-2017	10-Q
30	05-09-2017	03-31-2017	10-Q
31	02-28-2017	12-31-2016	10-K
32	11-04-2016	09-30-2016	10-Q
33	08-04-2016	06-30-2016	10-Q
34	04-29-2016	03-31-2016	10-Q
35	02-29-2016	12-31-2015	10-K
36	11-06-2015	09-30-2015	10-Q
37	08-12-2015	06-30-2015	10-Q
38	04-30-2015	03-31-2015	10-Q
39	02-26-2015	12-31-2014	10-K
40	11-05-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

upstart-insulet-and-2-other-stocks-executives-are-selling

Upstart, Insulet And 2 Other Stocks Execut...
09/12/2024 11:44:40

heres-how-much-1000-invested-in-insulet-15-years-ago-would-be-worth-today

Here's How Much $1000 Invested In Insulet ...
09/10/2024 16:00:14

affirm-mongodb-and-best-buy-are-among-top-10-large-cap-gainers-last-week-aug-25-aug-31-are-the-others-in-your-portfolio

Affirm, Mongodb And Best Buy Are Among Top...
09/02/2024 13:31:24

Top-performing large-cap stocks from last week: AFRM, NTNX, MDB, BBY, GEV, TCOM, COO, PODD, VEEV, AZPN.

(PODD) - Analyzing Insulet's Short Interest
08/30/2024 17:00:25

heres-how-much-you-would-have-made-owning-insulet-stock-in-the-last-10-years

Here's How Much You Would Have Made Owning...
08/28/2024 15:00:29

Insulet's Omnipod 5 Becomes First FDA-Clea...
08/26/2024 20:21:24

sp-500-nasdaq-100-snap-8-day-winning-streak-what-triggered-wall-streets-setback-on-tuesday

S&P 500, Nasdaq 100 Snap 8-Day Winning Str...
08/20/2024 20:39:21

S&P 500 ended Tuesday's session with slight declines, halting its best winning streak since May 2024. Here's the la...

The Latest Analyst Ratings For Insulet
08/12/2024 20:00:55

Peering Into Insulet's Recent Short Interest
08/12/2024 13:00:26

Barclays Maintains Equal-Weight on Insulet...
08/12/2024 12:29:07

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $200 to $220.

BTIG Maintains Buy on Insulet, Lowers Pric...
08/09/2024 17:20:02

BTIG analyst Marie Thibault maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $270 to $250.

wall-street-momentum-stalls-after-thursdays-rally-palantir-jumps-to-3-year-highs-bonds-rally-whats-driving-markets-friday

Wall Street Momentum Stalls After Thursday...
08/09/2024 17:13:36

After a blistering Thursday that saw the S&P 500 close with its best session in nearly two years — up 2.3% — Wall Street’s ...

insulin-pump-maker-insulets-growth-catalysts-set-to-boost-revenue-in-2025-analyst

Insulin Pump Maker Insulet's Growth Cataly...
08/09/2024 14:48:25

Insulet reported a Q2 adjusted EPS of $0.55, slightly missing estimates but showing strong sales growth of 23.2% year-over-year...

UBS Maintains Neutral on Insulet, Raises P...
08/09/2024 14:36:32

UBS analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $211 to $223.

Insulet Raises Q3 Revenue Growth 18%-21%
08/08/2024 20:06:19

Insulet Raises FY24 Revenue Growth From 14...
08/08/2024 20:06:10

Insulet Q2 2024 Adj EPS $0.55 Misses $0.56...
08/08/2024 20:03:22

Insulet (NASDAQ:PODD) reported quarterly earnings of $0.55 per share which missed the analyst consensus estimate of $0.56 by 1....

Insulet Q2 2024 Adj. EPS $0.55 Misses $0.5...
08/08/2024 20:02:46

Insulet (NASDAQ:PODD) reported quarterly earnings of $0.55 per share which missed the analyst consensus estimate of $0.56 by 1....

wall-street-rallies-as-economic-concerns-recede-tech-flexes-its-muscles-semiconductors-soar-whats-driving-markets-thursday

Wall Street Rallies As Economic Concerns R...
08/08/2024 17:19:57

Investor risk sentiment is showing greater conviction on Thursday, with all indices and major stock sectors in the green, after...

wall-street-set-for-uneventful-start-ahead-of-jobless-claim-data-vix-rises-strategist-says-market-may-remain-vulnerable-until

Wall Street Set For Uneventful Start Ahead...
08/08/2024 11:50:25

U.S. stocks are set for a mixed start on Thursday as concerns regarding the economy and incremental yen carry trade unwinding r...